Shares of Smith & Nephew plc (LON:SN) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1,666.44 and traded as high as $1,899.00. Smith & Nephew shares last traded at $1,898.50, with a volume of 1,958,914 shares.
A number of research analysts recently weighed in on SN shares. Shore Capital reaffirmed a “sell” rating on shares of Smith & Nephew in a research note on Wednesday, July 31st. UBS Group increased their price objective on Smith & Nephew from GBX 1,730 ($22.61) to GBX 1,830 ($23.91) and gave the stock a “neutral” rating in a research note on Tuesday, August 6th. Finally, Deutsche Bank reissued a “hold” rating on shares of Smith & Nephew in a research note on Friday, July 12th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of GBX 1,551.11 ($20.27).
The stock has a market capitalization of $16.44 billion and a PE ratio of 23.45. The firm has a 50 day moving average price of GBX 1,901.91 and a 200 day moving average price of GBX 1,668.76. The company has a quick ratio of 0.96, a current ratio of 2.00 and a debt-to-equity ratio of 44.00.
The firm also recently announced a dividend, which will be paid on Wednesday, October 30th. Stockholders of record on Thursday, October 3rd will be issued a $0.14 dividend. This represents a dividend yield of 0.62%. The ex-dividend date is Thursday, October 3rd. Smith & Nephew’s dividend payout ratio is presently 0.35%.
In other Smith & Nephew news, insider Virginia Bottomley bought 201 shares of Smith & Nephew stock in a transaction dated Friday, August 23rd. The stock was bought at an average cost of GBX 1,939 ($25.34) per share, with a total value of £3,897.39 ($5,092.63).
About Smith & Nephew (LON:SN)
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Recommended Story: What are the advantages to having securities held in street name?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.